You are here

  • Home
  • Archive
  • Volume 104, Issue 8
  • Twenty-four-month outcomes of inflammatory choroidal neovascularisation treated with intravitreal anti-vascular endothelial growth factors: a comparison between two treatment regimens

Article metrics

Article menu
Download PDFPDF
Clinical science
Twenty-four-month outcomes of inflammatory choroidal neovascularisation treated with intravitreal anti-vascular endothelial growth factors: a comparison between two treatment regimens

 

Online download statistics by month:

Online download statistics by month: November 2019 to March 2024

AbstractFullPdf
Nov 20191018513494
Dec 2019247613371298
Jan 2020256813131287
Feb 20201506794775
Mar 20201822913
Apr 202063156
May 202056212
Jun 2020135144
Jul 20204404626
Aug 20204963923
Sep 20201943110
Oct 202097208
Nov 2020871413
Dec 20209444
Jan 202118021
Feb 202198317
Mar 20219931
Apr 202110000
May 2021812
Jun 2021111
Jul 2021761
Aug 2021641
Sep 2021556
Oct 20214644
Nov 20214243
Dec 20214293
Jan 202212832
Feb 20225421
Mar 202214633
Apr 202216434
May 202217100
Jun 202230952
Jul 20225541
Aug 20227030
Sep 20229784
Oct 20226140
Nov 20226952
Dec 20224420
Jan 20232222
Feb 20235821
Mar 20235331
Apr 20234032
May 20233641
Jun 20232911
Jul 20232400
Aug 20236811
Sep 20234422
Oct 20232600
Nov 202311030
Dec 20236143
Jan 20243131
Feb 2024513217
Mar 20242656
Total1255543284050